128 related articles for article (PubMed ID: 30098478)
1. Meticulous optimization of cardiomyocyte yields in a 3-stage continuous integrated agitation bioprocess.
Ting S; Lam A; Tong G; Chen A; Wei H; Wu J; Lam YN; Reuveny S; Oh S
Stem Cell Res; 2018 Aug; 31():161-173. PubMed ID: 30098478
[TBL] [Abstract][Full Text] [Related]
2. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
Ting S; Chen A; Reuveny S; Oh S
Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
[TBL] [Abstract][Full Text] [Related]
3. Selection of human induced pluripotent stem cells lines optimization of cardiomyocytes differentiation in an integrated suspension microcarrier bioreactor.
Laco F; Lam AT; Woo TL; Tong G; Ho V; Soong PL; Grishina E; Lin KH; Reuveny S; Oh SK
Stem Cell Res Ther; 2020 Mar; 11(1):118. PubMed ID: 32183888
[TBL] [Abstract][Full Text] [Related]
4. Conjoint propagation and differentiation of human embryonic stem cells to cardiomyocytes in a defined microcarrier spinner culture.
Lam AT; Chen AK; Li J; Birch WR; Reuveny S; Oh SK
Stem Cell Res Ther; 2014 Sep; 5(5):110. PubMed ID: 25223792
[TBL] [Abstract][Full Text] [Related]
5. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
6. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells.
Chen VC; Ye J; Shukla P; Hua G; Chen D; Lin Z; Liu JC; Chai J; Gold J; Wu J; Hsu D; Couture LA
Stem Cell Res; 2015 Sep; 15(2):365-75. PubMed ID: 26318718
[TBL] [Abstract][Full Text] [Related]
7. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
[TBL] [Abstract][Full Text] [Related]
8. Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures.
Lecina M; Ting S; Choo A; Reuveny S; Oh S
Tissue Eng Part C Methods; 2010 Dec; 16(6):1609-19. PubMed ID: 20590381
[TBL] [Abstract][Full Text] [Related]
9. Cardiac differentiation of human pluripotent stem cells in scalable suspension culture.
Kempf H; Kropp C; Olmer R; Martin U; Zweigerdt R
Nat Protoc; 2015 Sep; 10(9):1345-61. PubMed ID: 26270394
[TBL] [Abstract][Full Text] [Related]
10. The impact of growth factors on human induced pluripotent stem cells differentiation into cardiomyocytes.
Yassa ME; Mansour IA; Sewelam NI; Hamza H; Gaafar T
Life Sci; 2018 Mar; 196():38-47. PubMed ID: 29337067
[TBL] [Abstract][Full Text] [Related]
11. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
Talkhabi M; Aghdami N; Baharvand H
Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
[TBL] [Abstract][Full Text] [Related]
12. Integrated processes for expansion and differentiation of human pluripotent stem cells in suspended microcarriers cultures.
Lam AT; Chen AK; Ting SQ; Reuveny S; Oh SK
Biochem Biophys Res Commun; 2016 May; 473(3):764-8. PubMed ID: 26385176
[TBL] [Abstract][Full Text] [Related]
13. Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension Culture.
Halloin C; Schwanke K; Löbel W; Franke A; Szepes M; Biswanath S; Wunderlich S; Merkert S; Weber N; Osten F; de la Roche J; Polten F; Christoph Wollert K; Kraft T; Fischer M; Martin U; Gruh I; Kempf H; Zweigerdt R
Stem Cell Reports; 2019 Aug; 13(2):366-379. PubMed ID: 31353227
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of human embryonic stem cells to cardiomyocytes on microcarrier cultures.
Ting S; Lecina M; Reuveny S; Oh S
Curr Protoc Stem Cell Biol; 2012 May; Chapter 1():Unit1D.7. PubMed ID: 22605644
[TBL] [Abstract][Full Text] [Related]
15. Developing a Cost-Effective and Scalable Production of Human Hepatic Competent Endoderm from Size-Controlled Pluripotent Stem Cell Aggregates.
Farzaneh Z; Najarasl M; Abbasalizadeh S; Vosough M; Baharvand H
Stem Cells Dev; 2018 Feb; 27(4):262-274. PubMed ID: 29298619
[TBL] [Abstract][Full Text] [Related]
16. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome dynamics of human pluripotent stem cell-derived contracting cardiomyocytes using an embryoid body model with fetal bovine serum.
Jung KB; Son YS; Lee H; Jung CR; Kim J; Son MY
Mol Biosyst; 2017 Jul; 13(8):1565-1574. PubMed ID: 28671202
[TBL] [Abstract][Full Text] [Related]
18. Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells.
Chen A; Ting S; Seow J; Reuveny S; Oh S
Stem Cell Res Ther; 2014 Jan; 5(1):12. PubMed ID: 24444355
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
[TBL] [Abstract][Full Text] [Related]
20. Microcarrier suspension cultures for high-density expansion and differentiation of human pluripotent stem cells to neural progenitor cells.
Bardy J; Chen AK; Lim YM; Wu S; Wei S; Weiping H; Chan K; Reuveny S; Oh SK
Tissue Eng Part C Methods; 2013 Feb; 19(2):166-80. PubMed ID: 22834957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
